Study protocol for J-SUPPORT 1604 (J-FORCE): A randomized, double blind, placebo-controlled Phase III study evaluating olanzapine (5 mg) plus standard triple antiemetic therapy for prevention of chemotherapy induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy

Hironobu Hashimoto, Masakazu Abe, Takako Yanai, Takuhiro Yamaguchi, Sadamoto Zenda, Yosuke Uchitomi, Haruhiko Fukuda, Mikio Mori, Satoru Iwasa, Noboru Yamamoto, Yuichiro Ohe

Research output: Contribution to journalArticle

4 Citations (Scopus)

Fingerprint Dive into the research topics of 'Study protocol for J-SUPPORT 1604 (J-FORCE): A randomized, double blind, placebo-controlled Phase III study evaluating olanzapine (5 mg) plus standard triple antiemetic therapy for prevention of chemotherapy induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences